Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing
about
Functional regulation of phospholipase D expression in cancer and inflammationKampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future applicationHelicobacter pylori and interleukin-8 in gastric cancerEfficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: a prospective randomized pilot study.Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicityRebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cellsRebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction.Protective Effect of Flos Lonicerae against Experimental Gastric Ulcers in Rats: Mechanisms of Antioxidant and Anti-Inflammatory Action.Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract.Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of β-Catenin.The Pattern of Use of Oral NSAIDs with or without Co-prescription of Gastroprotective Agent for Arthritic Knee by Korean PractitionersQuality of ulcer healing in gastrointestinal tract: its pathophysiology and clinical relevance.Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.Prospective multi-center trial for the efficacy of ecabet sodium on the relief of dyspepsia in korean patients with chronic gastritisEffect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy.Treatment of inflammatory bowel disease: a review of medical therapy.Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers.Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin testRebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: open label studyGastroprotective effect of Cochinchina momordica seed extract in nonsteroidal anti-inflammatory drug-induced acute gastric damage in a rat model.Accelerated Ulcer Healing and Resistance to Ulcer Recurrence with Gastroprotectants in Rat Model of Acetic Acid-induced Gastric Ulcer.A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.Gastro protective properties of the novel prostone SPI-8811 against acid-injured porcine mucosa.A simple high performance liquid chromatography method for determination of rebamipide in rat urine.Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase.Rebamipide: A Novel Agent in the Treatment of Recurrent Aphthous Ulcer and Behcet's Syndrome.Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye.
P2860
Q26829916-2931A5CA-A6AB-4760-B43E-BB0C27C0F03CQ26830898-6BA00C57-BA7B-45B4-8725-64EFA73E18A1Q26999701-3D202F0B-E77C-431A-8FD8-8AD952527D00Q33644828-C5B78D6F-0D20-4142-93ED-F00737A2D175Q33749848-EF3E3E88-CC31-4686-89C2-906AF8970C1FQ33959603-D7D73194-4CA1-41B2-A01C-29B002077AC1Q34086777-502D4E81-7560-49D5-8A9D-C0BA168D900FQ34609698-63FD684D-7764-4961-9DBE-18151BBD4704Q34913331-2784C6BA-44C0-428E-A531-2173B5DBA038Q35030764-599F71FB-4D34-46C1-ABEB-D2956772A184Q35680994-9DE89D00-A8AB-4FF2-A031-D80847254228Q35926946-5B343FE3-0EB4-4639-98BB-990479C50AF7Q36248155-9450B30C-F9C6-4389-8019-4E856A2178A3Q36291435-EEAD7E6C-F9AA-4ED0-AFCB-D3AFCCAAA808Q36459980-0E5FF8F0-DB4E-40AE-BA5F-AC1CB52965DDQ36499458-63E21E70-56E9-4693-BE68-BEF161768553Q37058862-5ACABBC9-FF45-46D6-B349-3F71711322FCQ37162479-926DF59D-1954-44CA-A03D-189B9C74A113Q37213371-EF3053E1-05E0-48E6-9605-160880F00C0AQ37301404-F7758061-D9E8-4E12-9038-E7E225DEE0C5Q37564030-BC4B4A22-D9AB-4B49-8D29-22BC297A5615Q38526218-82D55B4C-0F26-4F0C-840F-28D587AF94BCQ38599606-48BB3C86-50AD-40CC-92AB-81708B93F277Q41815252-5CFACEED-229A-49E1-9A0E-54498B9B8EB0Q41905852-DFDB5391-8CAA-4192-BE12-0F92F6C39B41Q42087629-F3C4E268-A34F-48FC-8AE0-FB2AB8391648Q42121542-C0E62340-66AB-490C-83C7-285212C6CB43Q47405249-8B2F4AD2-55A8-4F6E-AFE0-92AA8EE3E81F
P2860
Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Rebamipide: overview of its me ...... l protection and ulcer healing
@ast
Rebamipide: overview of its me ...... l protection and ulcer healing
@en
Rebamipide: overview of its me ...... l protection and ulcer healing
@nl
type
label
Rebamipide: overview of its me ...... l protection and ulcer healing
@ast
Rebamipide: overview of its me ...... l protection and ulcer healing
@en
Rebamipide: overview of its me ...... l protection and ulcer healing
@nl
prefLabel
Rebamipide: overview of its me ...... l protection and ulcer healing
@ast
Rebamipide: overview of its me ...... l protection and ulcer healing
@en
Rebamipide: overview of its me ...... l protection and ulcer healing
@nl
P2093
P1476
Rebamipide: overview of its me ...... l protection and ulcer healing
@en
P2093
A Tarnawski
K Kobayashi
T Yoshikawa
P304
P407
P433
P577
1998-09-01T00:00:00Z